In 2019, the Philadelphia region was home to just under 5,000 cell and gene therapy jobs. But in 2029, we could be looking at more than doubling that figure, a report commissioned by three regional economic and research groups found recently.

The Chamber of Commerce for Greater Philadelphia’s regional CEO Council for Growth, the University City Science Center, and University City District’s West Philadelphia Skills Initiative banded together with support from the Lenfest Foundation to take a closer look at the state of jobs in cell and gene therapy, along with the industry’s future.

The project, titled the “Cell and Gene Therapy and Connected Health Workforce Analysis,” found that cell and gene therapy jobs will likely grow between 35% to 94% in the next 10 years with mid-range growth estimates and as much as 54% to 136% with high-range growth estimates.

READ FULL ARTICLE HERE